1. Home
  2. RMT vs CTMX Comparison

RMT vs CTMX Comparison

Compare RMT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Micro-Cap Trust Inc.

RMT

Royce Micro-Cap Trust Inc.

N/A

Current Price

$12.92

Market Cap

771.7M

Sector

Finance

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$2.25

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMT
CTMX
Founded
1993
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
771.7M
716.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RMT
CTMX
Price
$12.92
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
86.5K
★ 3.2M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 7.37%
N/A
EPS Growth
N/A
N/A
EPS
★ 1.49
N/A
Revenue
N/A
★ $76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.24
P/E Ratio
★ $8.86
$22.58
Revenue Growth
★ N/A
N/A
52 Week Low
$9.52
$2.16
52 Week High
$14.78
$8.21

Technical Indicators

Market Signals
Indicator
RMT
CTMX
Relative Strength Index (RSI) 44.96 38.82
Support Level $12.88 $2.20
Resistance Level $14.32 $2.61
Average True Range (ATR) 0.25 0.15
MACD 0.05 0.02
Stochastic Oscillator 49.37 20.00

Price Performance

Historical Comparison
RMT
CTMX

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector, including diversified consumer services, hotels, household durables, leisure products, and luxury goods. Consumer staples sector, including beverages, food, and staples retailing, food products, and personal products, Energy sector, including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors, including healthcare, financials, industrials, IT, telecommunications, and materials.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: